Literature DB >> 12480731

Hypertension and related factors in the etiology of Alzheimer's disease.

Ingmar Skoog1, Deborah Gustafson.   

Abstract

The prevalence of hypertension is estimated to approach 50% in individuals above age 70. The consequences of hypertension include cerebrovascular disease, coronary heart disease, and general atherosclerosis. Several recent studies suggest that there may be an association also between hypertension and Alzheimer's disease (AD). This review will examine the evidence for this association and possible pathways between hypertension, Alzheimer encephalopathy, and clinical dementia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480731     DOI: 10.1111/j.1749-6632.2002.tb04796.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  Localized measures of callosal atrophy are associated with late-life hypertension: AGES-Reykjavik Study.

Authors:  Peter Harris; Dan A Alcantara; Nina Amenta; Oscar L Lopez; Gudný Eiríksdóttir; Sigurdur Sigurdsson; Villmundur Gudnason; Sarah Madsen; Paul M Thompson; Lenore J Launer; Owen T Carmichael
Journal:  Neuroimage       Date:  2008-07-18       Impact factor: 6.556

2.  Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.

Authors:  Markus Bleckwenn; Luca Kleineidam; Michael Wagner; Frank Jessen; Siegfried Weyerer; Jochen Werle; Birgitt Wiese; Dagmar Lühmann; Tina Posselt; Hans-Helmut König; Christian Brettschneider; Edelgard Mösch; Dagmar Weeg; Angela Fuchs; Michael Pentzek; Tobias Luck; Steffi G Riedel-Heller; Wolfgang Maier; Martin Scherer
Journal:  Br J Gen Pract       Date:  2016-12-19       Impact factor: 5.386

3.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.

Authors:  Laibaik Park; Ping Zhou; Rose Pitstick; Carmen Capone; Josef Anrather; Erin H Norris; Linda Younkin; Steven Younkin; George Carlson; Bruce S McEwen; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

4.  Comprehensive gene expression profiling reveals synergistic functional networks in cerebral vessels after hypertension or hypercholesterolemia.

Authors:  Wei-Yi Ong; Mary Pei-Ern Ng; Sau-Yeen Loke; Shalai Jin; Ya-Jun Wu; Kazuhiro Tanaka; Peter Tsun-Hon Wong
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

5.  Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons.

Authors:  L B Hoffman; J Schmeidler; G T Lesser; M S Beeri; D P Purohit; H T Grossman; V Haroutunian
Journal:  Neurology       Date:  2009-02-18       Impact factor: 9.910

6.  Cardiovascular disease could be contained based on currently available data!

Authors:  Okom Nkili F C Ofodile
Journal:  Dose Response       Date:  2006-09-23       Impact factor: 2.658

7.  Influence of social support on cognitive change and mortality in old age: results from the prospective multicentre cohort study AgeCoDe.

Authors:  Marion Eisele; Thomas Zimmermann; Mirjam Köhler; Birgitt Wiese; Kathrin Heser; Franziska Tebarth; Dagmar Weeg; Julia Olbrich; Michael Pentzek; Angela Fuchs; Siegfried Weyerer; Jochen Werle; Hanna Leicht; Hans-Helmut König; Melanie Luppa; Steffi Riedel-Heller; Wolfgang Maier; Martin Scherer
Journal:  BMC Geriatr       Date:  2012-03-20       Impact factor: 3.921

8.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

9.  A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 mice.

Authors:  Diane Jansen; Valerio Zerbi; Carola I F Janssen; Pieter J W C Dederen; Martina P C Mutsaers; Anne Hafkemeijer; Anna-Lena Janssen; Cindy L M Nobelen; Andor Veltien; Jack J Asten; Arend Heerschap; Amanda J Kiliaan
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  The Alzheimer's disease beta-secretase enzyme, BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Mol Neurodegener       Date:  2007-11-15       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.